ConductScience.org, home

Paper40945847

Advances in high-throughput drug screening based on pharmacotranscriptomics.

Qiao L and 7 others. J Adv Res, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Advances in high-throughput drug screening based on pharmacotranscriptomics. Papers, record 40945847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40945847

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in high-throughput drug screening based on pharmacotranscriptomics.
PubMed
Journal
J Adv Res
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qiao LLiansheng
2Huo XXiaoqian
3Huang WWenting
4Wang ZZewen
5Ren YYue
6Liu YYanxia
7Li QQun
8Zhang YYanling

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
High-Throughput Screening AssaysMajor topic
Drug DiscoveryMajor topic
PharmacogeneticsMajor topic
TranscriptomeMajor topic
Humans
Drug Evaluation, Preclinical
Animals
Artificial Intelligence
Gene Expression Profiling

Source PubMed

Download CSV of topics

References150

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135945222Connecting omics signatures and revealing biological mechanisms with iLINCS.Nat Commun2022https://conductscience.org/library/papers/35945222PubMed
230552330Drug and disease signature integration identifies synergistic combinations in glioblastoma.Nat Commun2018https://conductscience.org/library/papers/30552330PubMed
334696786Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34696786PubMed
439213358Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking.Sci Adv2024https://conductscience.org/library/papers/39213358PubMed
538816426Identification of drug responsive enhancers by predicting chromatin accessibility change from perturbed gene expression profiles.NPJ Syst Biol Appl2024https://conductscience.org/library/papers/38816426PubMed
638918369Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery.Nat Commun2024https://conductscience.org/library/papers/38918369PubMed
736805225Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.Comput Biol Med2023https://conductscience.org/library/papers/36805225PubMed
837666060A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.Phytomedicine2023https://conductscience.org/library/papers/37666060PubMed
939558177HERB 2.0: an updated database integrating clinical and experimental evidence for traditional Chinese medicine.Nucleic Acids Res2025https://conductscience.org/library/papers/39558177PubMed
1039340453Multiplexed Target Profiling with Integrated Chemical Genomics and Chemical Proteomics.J Med Chem2024https://conductscience.org/library/papers/39340453PubMed
1128933291Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease.Curr Med Chem2018https://conductscience.org/library/papers/28933291PubMed
1239973082iDOMO: identification of drug combinations via multi-set operations for treating diseases.Brief Bioinform2024https://conductscience.org/library/papers/39973082PubMed
1338378612A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer.BioData Min2024https://conductscience.org/library/papers/38378612PubMed
1433657393The phytochemical hyperforin triggers thermogenesis in adipose tissue via a Dlat-AMPK signaling axis to curb obesity.Cell Metab2021https://conductscience.org/library/papers/33657393PubMed
1534933331TMNP: a transcriptome-based multi-scale network pharmacology platform for herbal medicine.Brief Bioinform2022https://conductscience.org/library/papers/34933331PubMed
1633264402HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine.Nucleic Acids Res2021https://conductscience.org/library/papers/33264402PubMed
1739303708Identifying compound-protein interactions with knowledge graph embedding of perturbation transcriptomics.Cell Genom2024https://conductscience.org/library/papers/39303708PubMed
1837365273Gene regulatory network inference in the era of single-cell multi-omics.Nat Rev Genet2023https://conductscience.org/library/papers/37365273PubMed
1929416003The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.Cell Death Dis2018https://conductscience.org/library/papers/29416003PubMed
2023586463Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.BMC Bioinformatics2013https://conductscience.org/library/papers/23586463PubMed

See all 150 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42871545Screening for medicine and food homologous ingredients targeting ALDH2 to alleviate acute ethanol-induced liver injury.Front Nutr2026https://conductscience.org/library/papers/42871545PubMed
42764382FuTCM-PDD: a multi-level information fusion framework integrating KAN modeling and AutoML for phenotype-based drug discovery from Traditional Chinese Medicine.Chin Med2026https://conductscience.org/library/papers/42764382PubMed
41638902Applying biotechnology to overcome cancer drug resistance and improve public health outcomes.Osong Public Health Res Perspect2026https://conductscience.org/library/papers/41638902PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40945847

GET https://conductscience.org/api/papers/v1/40945847/references?page=2